Angiotech Pharmaceuticals says pre-market approval needed for Bio-Seal

By The Associated Press

Monday, October 19, 2009

[-] Text [+]

Read/Post Comments

VANCOUVER — Angiotech Pharmaceuticals, Inc. (TSX:ANP) said Monday that the U.S. Food and Drug Administration has ruled that the company needs pre-market approval for its Bio-Seal product. The company said it was reviewing its options, including possibly appealing the FDA decision, and was in talks with its partner, Biopsy Sciences, LLC.

Click here to follow PD&D on Twitter

ALSO ON PD&D

RELATED TOPICS

Internet Believers: Pastors Open Online Churches 11/3/2009

Chinese Site To Steer Users To Legit Music Source 11/3/2009

New Service Helps Internet Users Manage Their Own Search 11/3/2009

Oregon auto retailer plans to buy more dealerships 10/31/2009

SEC alleges insider trading at San Francisco fund 10/31/2009

Angiotech Pharmaceuticals

JOIN THE DISCUSSION
Rate Article:

Average 0 out of 5

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

At Issue

10 Years Ago, A Paradigm Shift Began
Dr. Ron L. Hollis, P.E., Quickparts.com

Foreign Corporations Find Trouble In N. American Markets
Jeff Klingberg, Fluid Power Technologies

Emergency Stopping
Professor MC, Motion Control Guru, PD&D

More At Issue

Quick Links

Site Sponsors

Videos & Webcasts

XStreamHD: An HD Revolution 2/8/2010
XStreamHD gives in-home access of full HD entertainment. Continue

Living With Robots 2/4/2010
Take a peek into Honda’s creation, ASIMO; a reflection of human’s technological evolutions. Continue

Pick-And-Place Motion Control 2/4/2010
TECHNOSOFT Servo Drives offer extended flexibility and versatility resulting in easy-to-use solutions. Continue